Functional role of endothelial CXCL16/CXCR6-platelet–leucocyte axis in angiotensin II-associated metabolic disorders
- 23 May 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 114 (13) , 1764-1775
Abstract
Angiotensin-II (Ang-II) is the main effector peptide of the renin–angiotensin system (RAS) and promotes leucocyte adhesion to the stimulated endothelium. Because RAS activation and Ang-II signalling are implicated in metabolic syndrome (MS) and abdominal aortic aneurysm (AAA), we investigated the effect of Ang-II on CXCL16 arterial expression, the underlying mechanisms, and the functional role of the CXCL16/CXCR6 axis in these cardiometabolic disorders. Results from in vitro chamber assays revealed that CXCL16 neutralization significantly inhibited mononuclear leucocyte adhesion to arterial but not to venous endothelial cells. Flow cytometry and immunofluorescence studies confirmed that Ang-II induced enhanced endothelial CXCL16 expression, which was dependent on Nox5 up-regulation and subsequent RhoA/p38-MAPK/NFκB activation. Flow cytometry analysis further showed that MS patients had higher levels of platelet activation and a higher percentage of circulating CXCR6-expressing platelets, CXCR6-expressing-platelet-bound neutrophils, monocytes, and CD8+ lymphocytes than age-matched controls, leading to enhanced CXCR6/CXCL16-dependent adhesion to the dysfunctional (Ang-II- and TNFα-stimulated) arterial endothelium. Ang-II-challenged apolipoprotein E-deficient (apoE−/−) mice had a higher incidence of AAA, macrophage, CD3+, and CXCR6+ cell infiltration and neovascularization than unchallenged animals, which was accompanied by greater CCL2, CXCL16, and VEGF mRNA expression within the lesion together with elevated levels of circulating soluble CXCL16. Significant reductions in these parameters were found in animals co-treated with the AT1 receptor antagonist losartan or in apoE−/− mice lacking functional CXCR6 receptor (CXCR6GFP/GFP). CXCR6 expression on platelet-bound monocytes and CD8+ lymphocytes may constitute a new membrane-associated biomarker for adverse cardiovascular events. Moreover, pharmacological modulation of this axis may positively affect cardiovascular outcome in metabolic disorders linked to Ang-II.Keywords
Funding Information
- Spanish Ministry of Economy and Competiveness (SAF2011-23777, SAF2014-57845R, CPII13/00025, PI15/00082, PIE15/00013, GVACOMP2014-006, PROMETEO II/2013/014)
- Carlos III Health Institute
- European Regional Development Fund
- Generalitat Valenciana
- Spanish Ministry of Education
- Spanish Ministry of Innovation and Competitiveness
- Generalitat Valenciana
This publication has 41 references indexed in Scilit:
- Associations of CXCL16/CXCR6 with carotid atherosclerosis in patients with metabolic syndromeClinical Nutrition, 2013
- Arterial and Venous Endothelia Display Differential Functional Fractalkine (CX 3 CL1) Expression by Angiotensin-IIArteriosclerosis, Thrombosis, and Vascular Biology, 2013
- Role of reactive oxygen and nitrogen species in the vascular responses to inflammationFree Radical Biology and Medicine, 2012
- Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 5 (Nox5) Regulation by Angiotensin II and Endothelin-1 Is Mediated via Calcium/Calmodulin-Dependent, Rac-1-Independent Pathways in Human Endothelial CellsCirculation Research, 2010
- NADPH Oxidases: Functions and Pathologies in the VasculatureArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE−/− miceClinical Science, 2010
- Simvastatin Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-Knockout MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- CXCR6 Induces Prostate Cancer Progression by the AKT/Mammalian Target of Rapamycin Signaling PathwayCancer Research, 2008
- A transmembrane chemokine, CXC chemokine ligand 16, expressed by lymph node fibroblastic reticular cells has the potential to regulate T cell migration and adhesionInternational Immunology, 2006
- Tissue Angiotensin and Pathobiology of Vascular DiseaseHypertension, 2001